Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrike Veith

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|December 19, 2009
Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseMatthew B Boxer, Jian-kang Jiang, Matthew G Vander Heiden, et al.
The Biochemical Journal|August 22, 2012
A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinaseHugh P Morgan, Martin J Walsh, Elizabeth A Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2008
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluationChristopher M Tegley, Vellarkad N Viswanadhan, Kaustav Biswas, et al.
Nature Chemical Biology|August 28, 2012
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesisDimitrios Anastasiou, Yimin Yu, William J Israelsen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Medicinal Chemistry|December 19, 2009
Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinaseMatthew B Boxer, Jian-kang Jiang, Matthew G Vander Heiden, et al.
The Biochemical Journal|August 22, 2012
A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinaseHugh P Morgan, Martin J Walsh, Elizabeth A Blackburn, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2008
Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluationChristopher M Tegley, Vellarkad N Viswanadhan, Kaustav Biswas, et al.
Nature Chemical Biology|August 28, 2012
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesisDimitrios Anastasiou, Yimin Yu, William J Israelsen, et al.
Pageof 2